Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
Abstract Background The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously perform...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13756-019-0663-7 |
id |
doaj-a41bfe28cd8541b8840fbb0af6423db5 |
---|---|
record_format |
Article |
spelling |
doaj-a41bfe28cd8541b8840fbb0af6423db52021-01-17T12:03:28ZengBMCAntimicrobial Resistance and Infection Control2047-29942020-01-019111310.1186/s13756-019-0663-7Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017Eline Vandael0Katrien Latour1Herman Goossens2Koen Magerman3Nico Drapier4Boudewijn Catry5Ann Versporten6the Belgian Point Prevalence Survey Study GroupHealthcare-associated infections and antimicrobial resistance, SciensanoHealthcare-associated infections and antimicrobial resistance, SciensanoLaboratory of Medical Microbiology, University of AntwerpBelgian Antibiotic Policy Coordination Commission (BAPCOC), Direction General Healthcare, Federal Public Service Health, Food Chain Safety and EnvironmentLaboratory of Medical Microbiology, University of AntwerpHealthcare-associated infections and antimicrobial resistance, SciensanoLaboratory of Medical Microbiology, University of AntwerpAbstract Background The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017. Methods Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September–December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS. Results Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5–27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8–7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%). Conclusions HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI.https://doi.org/10.1186/s13756-019-0663-7Point prevalence surveyAntimicrobial consumptionHealthcare-associated infectionsBelgiumAcute care hospitals |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eline Vandael Katrien Latour Herman Goossens Koen Magerman Nico Drapier Boudewijn Catry Ann Versporten the Belgian Point Prevalence Survey Study Group |
spellingShingle |
Eline Vandael Katrien Latour Herman Goossens Koen Magerman Nico Drapier Boudewijn Catry Ann Versporten the Belgian Point Prevalence Survey Study Group Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 Antimicrobial Resistance and Infection Control Point prevalence survey Antimicrobial consumption Healthcare-associated infections Belgium Acute care hospitals |
author_facet |
Eline Vandael Katrien Latour Herman Goossens Koen Magerman Nico Drapier Boudewijn Catry Ann Versporten the Belgian Point Prevalence Survey Study Group |
author_sort |
Eline Vandael |
title |
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_short |
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_full |
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_fullStr |
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_full_unstemmed |
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_sort |
point prevalence survey of antimicrobial use and healthcare-associated infections in belgian acute care hospitals: results of the global-pps and ecdc-pps 2017 |
publisher |
BMC |
series |
Antimicrobial Resistance and Infection Control |
issn |
2047-2994 |
publishDate |
2020-01-01 |
description |
Abstract Background The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017. Methods Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September–December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS. Results Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5–27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8–7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%). Conclusions HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI. |
topic |
Point prevalence survey Antimicrobial consumption Healthcare-associated infections Belgium Acute care hospitals |
url |
https://doi.org/10.1186/s13756-019-0663-7 |
work_keys_str_mv |
AT elinevandael pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT katrienlatour pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT hermangoossens pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT koenmagerman pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT nicodrapier pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT boudewijncatry pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT annversporten pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT thebelgianpointprevalencesurveystudygroup pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 |
_version_ |
1724335515582332928 |